Naploy Revenue, Net Income & 10-K Summary

Company basics

Jurisdiction and date: Incorporated in Wyoming; established April 6, 2023.
Legal name: Naploy Corp. (referred to as the “Company,” “we,” “our”).
Primary focus: Launching a health-focused news blog and related app-based services under the Naploy brand.
Principal office: 95 Lias Estate, Kafe District, Abuja, FCT 900108, Nigeria. Phone: +1 307-213-3163.
Officers / directors: Frederick Sidney Reinhard Arnold and Rafael Angel Ulloa Bonilla.
Employees: Officers/directors only; no other employees.

Core products: Naploy App (Android and iOS) and Naploy web presence.
App launch: Published on the Apple App Store and Google Play Store on July 24, 2023.
Reported users: More than 10 active users.

News blog: Article library covering nutrition, fitness, weight control, disease, health trends, and health research. Content is sourced from reputable open channels and curated from medicalxpress.com; editors hand-process each story.
Symptom diagnostic: AI-powered tool that collects age, gender, symptoms, duration, intensity, medical history, and medications to return a short list (about five) of possible conditions. The tool is informational and not a definitive diagnostic instrument. The app and website present information rather than direct medical advice and do not require regulatory approval for that purpose.
Clinic search: Fee-based service where users submit name, phone, email and location; the team clarifies needs, searches and quality-checks institutions and doctors, and delivers up to five recommended options with follow-up support.

Planned improvements and new features:

Health content updated regularly by healthcare professionals and industry experts.
Content sourcing relies on open sources; the Company does not use paid licensing agreements for curated content.

The app emphasizes informational use and directs users to seek professional medical consultation for severe symptoms.
Data protection: States compliance with the Nigerian Data Protection Regulation (NDPR).
Regulatory context: The Company recognizes relevant Nigerian and U.S. healthcare and technology frameworks, including the National Health Act and Companies and Allied Matters Act (CAMA). Regulatory changes may require process adjustments; the Company reports no material regulatory impact at present.

Current revenue streams: Advertising and fee-based Clinic Search. The Company has not established referral contracts with medical institutions.
Current pricing (illustrative ranges):
- Advertising: $0.50–$1.00 per click; monthly advertising packages $150–$1,000.
- Clinic Search: $50–$500 per search, depending on complexity and support required.
Potential future revenue streams:
- Subscription model starting at $70 per month
- Referral fees of 5%–15% of service cost
- Data analytics reports priced $200–$2,000 depending on detail and analysis
Data analytics approach: Offer anonymized data products for healthcare providers and researchers.
Purchase of technology assets: Naploy app and website (iOS/Android) acquired for US $45,000.

Competitive landscape: Competes with platforms such as Zocdoc, Healthgrades, and WebMD, as well as other health apps offering related features.
Marketing approach: Digital marketing (SEO, PPC, social media, email), content marketing, influencer partnerships, future partnerships with medical institutions, word-of-mouth, and targeted outdoor advertising.

Real estate: No owned or leased real estate; executive-provided office space in Abuja provided free of charge.
Intellectual property: No patents or trademarks registered or owned.
Cybersecurity: No third-party cybersecurity provider engaged; the Company reports no cybersecurity incidents to date.

Compliance: Cites relevant regulations (NDPR, National Health Act, CAMA) and reports compliance with NDPR.
Regulatory outlook: The Company monitors changes in healthcare and data protection rules and will adjust processes as required.

Focus on expanding the user base and feature set in Nigeria, then evaluate readiness and demand for regional expansion across selected African markets.